Insiders · CRVS

Edith P. Mitchell

Director at Corvus Pharmaceuticals, Inc. (CRVS)

Edith P. Mitchell has filed 6 insider reports with the SEC since June 2021, as director at Corvus Pharmaceuticals, Inc. (CRVS). The latest filing, on December 8, 2023, reports grant or award at Corvus Pharmaceuticals, Inc. (CRVS).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Edith P. Mitchell is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Corvus Pharmaceuticals, Inc. logo
CRVS
Corvus Pharmaceuticals, Inc.
Director$9.67Dec 8, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Edith P. Mitchell with

Other insiders at the same companies

Questions about Edith P. Mitchell

What is Edith P. Mitchell's role at Corvus Pharmaceuticals, Inc.?
Edith P. Mitchell reports to the SEC as director at Corvus Pharmaceuticals, Inc. (CRVS), according to the latest filing on December 8, 2023.
Has Edith P. Mitchell bought or sold stock recently?
No open-market purchases or sales by Edith P. Mitchell are on file. The filings report grant or award.
How do I get alerts when Edith P. Mitchell files?
Follow Edith P. Mitchell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Edith P. Mitchell (SEC CIK 0001484982). Totals count each trade once, skipping amendments whose original is on file, from Jun 16, 2021 on. View on SEC EDGAR · Get this as JSON